Skip to main content
Clinical Trials/NL-OMON51635
NL-OMON51635
Recruiting
Phase 2

Prospective clinical trial to evaluate the efficacy of acetazolamide for the treatment of cystoid macular edema in inherited retinal dystrophies: the CAR trial - The CAR trial

Amsterdam UMC0 sites18 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Inherited retinal dystrophies
Sponsor
Amsterdam UMC
Enrollment
18
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Amsterdam UMC

Eligibility Criteria

Inclusion Criteria

  • Eligible patients received a clinical diagnosis of IRD, and underwent at least
  • one clinical examination, in combination with one of the following
  • prerequisites:
  • IRD associated with causal genetic variant(s) (in e.g., USH2A, CRB1, RHO,
  • RP1, RP2, RPGR, PRPF31, or RS1 gene)
  • CME involving the fovea confirmed on spectral\-domain optical coherence
  • tomography (OCT)

Exclusion Criteria

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:
  • Eyes will be excluded when the visual dysfunction is also significantly
  • associated with other ocular diseases besides the IRDs (e.g., glaucoma,
  • perforating trauma).
  • Patients treated with loop diuretics
  • Severe hepatic impairment
  • Severe renal insufficiency
  • Sodium and Potassium Depletion
  • Addison's disease

Outcomes

Primary Outcomes

Not specified

Similar Trials